Table 2.
Mean ± SEM values of clinical, metabolic, and hormonal values in the two subgroups of heart failure, with preserved or reduced ejection fraction (HFpEF and HFrEF, respectively).
| HFpEF | HFrEF | p | |
|---|---|---|---|
| NHYA class | II (n = 12) | II (n = 10) | |
| III (n = 18) | III (n = 10) | ||
| NT-proBNP (pg/ml) | 2862.2 ± 488.5 | 7500.16 ± 2459.5 | <0.05 |
| Total cholesterol (mg/dl) | 125.5 ± 6.9 | 153.6 ± 10.9 | <0.05 |
| HDL-C (mg/dl) | 34.4 ± 2 | 44.47 ± 5.2 | n.s. |
| LDL-C (mg/dl) | 75.7 ± 7.3 | 91.36 ± 7.3 | n.s. |
| Creatinine (mg/dl) | 1.3 ± 0.1 | 1.27 ± 0.1 | n.s. |
| Insulin (μUI/ml) | 11.8 ± 1.4 | 25.32 ± 9.9 | n.s. |
| Glucose (mg/dl) | 88.5 ± 4.7 | 94.95 ± 8.4 | n.s. |
| HOMA-IR | 2.8 ± 0.5 | 3.68 ± 1.3 | n.s. |
| BMI (kg/m2) | 28.7 ± 1.1 | 28.03 ± 1.2 | n.s. |
| IGF-1 (ng/ml) | 89.4 ± 7.1 | 112.78 ± 11.8 | n.s. |
| DHEA-S (ng/ml) | 438.9 ± 61.1 | 564.1 ± 140.3 | n.s. |
| TSH (μU/ml) | 2.5 ± 0.5 | 2.82 ± 1.0 | n.s. |
| fT3 (pg/ml) | 2.4 ± 0.1 | 2.5 ± 0.1 | n.s. |
| fT4 (pg/ml) | 11.3 ± 0.5 | 11.28 ± 0.5 | n.s. |
| T (ng/ml) | 2.4 ± 0.2 | 3.55 ± 0.5 | <0.05 |
| LAG (sec) | 83 ± 6.7 | 75.77 ± 7.5 | n.s. |